Free Trial

MediWound (MDWD) SEC Filings & 10K Form

MediWound logo
$16.00 -0.37 (-2.26%)
(As of 11/15/2024 ET)

Recent MediWound SEC Filings

DateFilerForm TypeView
11/14/2024
6:55 PM
MediWound (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
10/23/2024
1:57 PM
MediWound (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G/A
10/01/2024
7:23 AM
MediWound (Subject)
Yelin Lapidot Holdings Management Ltd. (Filed by)
Form SC 13G
09/09/2024
11:15 PM
MediWound (Filer)
Form EFFECT
09/09/2024
3:47 PM
MediWound (Filer)
Form 424B3
08/29/2024
3:44 PM
MediWound (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
08/15/2024
3:20 PM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:07 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:21 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/05/2024
7:53 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/19/2024
3:30 PM
MediWound (Subject)
Molnlycke Health Care AB (Filed by)
Form SC 13D
07/19/2024
3:01 PM
Access Industries Holdings LLC (Filed by)
MediWound (Subject)
Form SC 13D/A
07/16/2024
6:35 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
6:05 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
4:43 PM
MediWound (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G/A
07/09/2024
3:05 PM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/29/2024
6:05 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
6:22 PM
MediWound (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G/A
03/21/2024
7:08 AM
MediWound (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/21/2024
6:05 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
7:43 PM
MediWound (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G/A
02/12/2024
6:05 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
6:05 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
6:00 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2024
6:05 AM
Deep Insight Limited Partnership (Filed by)
MediWound (Subject)
Form SC 13G/A
01/08/2024
5:35 AM
Israel Biotech Fund II, L.P. (Filed by)
MediWound (Subject)
Form SC 13G/A
12/28/2023
6:05 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2023
6:03 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2023
6:05 AM
MediWound (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MDWD) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners